Bempedoic acid (Synonyms: ETC-1002; ESP-55016)

Name: Bempedoic acid
Brand: MedChemExpress
SKU: HY-12357
Rating: 5.0 (22 reviews)

Cat. No.: HY-12357 Pureté: 99.88%: Fiche technique
COA

SDS
Instruction de manipulation
FAQs
Technical Support

Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor. Bempedoic acid (ETC-1002) activates AMPK.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

CAS No. : 738606-46-7

Size	Stock	Quantité

Échantillon gratuit (0.1 - 0.2 mg)	Appliquer maintenant
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	En stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	En stock	Estimated Time of Arrival: December 31
Solid
5 mg	En stock	Estimated Time of Arrival: December 31
10 mg	En stock	Estimated Time of Arrival: December 31
25 mg	En stock	Estimated Time of Arrival: December 31
50 mg	En stock	Estimated Time of Arrival: December 31
100 mg	En stock	Estimated Time of Arrival: December 31
250 mg	En stock	Estimated Time of Arrival: December 31
500 mg	En stock	Estimated Time of Arrival: December 31
1 g	Obtenir un devis
5 g	Obtenir un devis

or Bulk Inquiry

* Veuillez sélectionner la quantité avant d'ajouter des articles.

This product is a controlled substance and not for sale in your territory.

Avis client

Based on 22 publication(s) in Google Scholar

Other Forms of Bempedoic acid:

Bempedoic acid-d₅ In-stock
Bempedoic acid-d₄ In-stock
Bempedoic acid (Standard) Obtenir un devis

22 Publications Citing Use of MCE Bempedoic acid

Bio/Physico-chemical Assay

RT-PCR

Histological Imaging/Staining

Cell Imaging/Staining

: Bempedoic acid purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2025 Jan 30:184:117876. [Abstract]; Bempedoic acid (BemA) (30 mg/kg, i.g.) attenuated the compensatory increase in aortic collagen I expression and decreased the enhanced vascular expression of Mmp-2 induced by Ang II and lowered Mmp-9 mRNA levels compared with mice receiving Ang II alone.

: Bempedoic acid purchased from MedChemExpress. Usage Cited in: Cell Metab. 2025 Jan 7;37(1):239-254.e7. [Abstract]; Bempedoic acid (BPA) (30 mg/kg, i.g.) yielded a significant reduction in total DNL in mice consuming sweetened water.

: Bempedoic acid purchased from MedChemExpress. Usage Cited in: Cell Metab. 2025 Jan 7;37(1):239-254.e7. [Abstract]; Bempedoic acid (BPA) (30 mg/kg, i.g.) also promoted ACSS2 upregulation and increases in pAMPK by western blot.

: Bempedoic acid purchased from MedChemExpress. Usage Cited in: Cell Metab. 2025 Jan 7;37(1):239-254.e7. [Abstract]; Treatment with Bempedoic acid (BPA) (30 mg/kg, i.g.) abrogated the genotype-dependent difference in liver weight and dramatically suppressed steatosis in both WT and LAKO mice.

: Bempedoic acid purchased from MedChemExpress. Usage Cited in: Cell Metab. 2025 Jan 7;37(1):239-254.e7. [Abstract]; Treatment with Bempedoic acid (BPA) (30 mg/kg, i.g.) abrogated the genotype-dependent difference in liver weight and dramatically suppressed steatosis in both WT and LAKO mice.

Recommandations en vedette

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Voir tous les produits spécifiques à Isoform AMPK:

Voir toutes les isoformes

NUAK1 NUAK2 AMPK AMPK α1β1γ1 AMPK α2β1γ1 AMPK α1β2γ1 AMPK α2β2γ1 BRSK1 BRSK2 HUNK AMPKα

Activité biologique
Protocole
Pureté et documentation
Références
Avis client

Description

Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor^[1]. Bempedoic acid (ETC-1002) activates AMPK^[2].

IC₅₀ & Target^[1]

AMPK

In Vitro

Bempedoic acid (ETC-1002) activates AMP-activated protein kinase in a Ca²⁺/calmodulin-dependent kinase β-independent and liver kinase β 1-dependent manner, without detectable changes in adenylate energy charge. Bempedoic acid is shown to rapidly form a CoA thioester in liver, which directly inhibits ATP-citrate lyase^[1]. In cells treated with Bempedoic acid (ETC-1002), increased levels of AMP-activated protein kinase (AMPK) phosphorylation coincide with reduced activity of MAP kinases and decreased production of proinflammatory cytokines and chemokines^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

A marked and sustained increase in AMPK and ACC phosphorylation is found in rat livers following two weeks of treatment with Bempedoic acid (ETC-1002). Bempedoic acid is >100-fold more prevalent than the CoA thioester in rat liver and is associated with AMPK activation^[1]. Bempedoic acid (ETC-1002) suppresses thioglycollate-induced homing of leukocytes into mouse peritoneal cavity. In a mouse model of diet-induced obesity, Bempedoic acid restores adipose AMPK activity, reduces JNK phosphorylation, and diminishes expression of macrophage-specific marker 4F/80^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Essai clinique

Masse moléculaire

344.49

Formule

C₁₉H₃₆O₅

CAS No.

738606-46-7

Appearance

Solid

Color

White to light yellow

SMILES

O=C(O)C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(O)=O

Livraison

Room temperature in continental US; may vary elsewhere.

Stockage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvant et solubilité

In Vitro:

DMSO : 100 mg/mL (290.28 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.9028 mL	14.5142 mL	29.0284 mL
5 mM	0.5806 mL	2.9028 mL	5.8057 mL
10 mM	0.2903 mL	1.4514 mL	2.9028 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Calculateur de molarité
Calculateur de dilution

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 5% DMSO 40% PEG300 5% Tween-80 50% Saline
Solubility: ≥ 2.87 mg/mL (8.33 mM); Clear solution
Protocol 2

Add each solvent one by one: 5% DMSO 95% (20% SBE-β-CD in Saline)
Solubility: 2.87 mg/mL (8.33 mM); Suspended solution; Need ultrasonic
Protocol 3

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (7.26 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 4

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (7.26 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 5

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (7.26 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.
Protocol 6

Add each solvent one by one: 1% DMSO 99% Saline
Solubility: 0.57 mg/mL (1.65 mM); Suspended solution; Need ultrasonic

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Pureté et documentation

Purity: 99.88%

Select Batch:

Fiche technique (273 KB) SDS (393 KB)

COA (240 KB) HNMR (253 KB) RP-HPLC (245 KB)

Instruction de manipulation (2659 KB)

Références

[1]. Pinkosky SL, et al. AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism. J Lipid Res. 2013 Jan;54(1):134-51. [Content Brief]

[2]. Filippov S, et al. ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK. J Lipid Res. 2013 Aug;54(8):2095-108. [Content Brief]

Test cellulaire ^[1]	Glucose production is measured in primary rat hepatocyte cultures. Cells are cultured in glucose- and phenol red-free DMEM, containing 10 mM lactate, 1 mM pyruvate, and nonessential amino acids. Cells are incubated with various concentrations of Bempedoic acid (0.1 to 100 μM)^[1]. MCE n'a pas confirmé de manière indépendante l'exactitude de ces méthodes. Ils sont pour référence seulement.
Administration animale ^[1]	Rats: Prior to single-dose Bempedoic acid administration, Male Wistar Han rats are fasted for 48 h and refed a high-carbohydrate diet for an additional 48 h. For two-week assessment, rats are maintained on standard chow diet and dosed by oral gavage with Bempedoic acid at 30 mg/kg/day for two weeks in the morning. Following nutritional staging and/or dosing, food is withdrawn 2 h prior to last the oral dose of ehicle control or Bempedoic acid^[1]. MCE n'a pas confirmé de manière indépendante l'exactitude de ces méthodes. Ils sont pour référence seulement.
Références	[1]. Pinkosky SL, et al. AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism. J Lipid Res. 2013 Jan;54(1):134-51. [Content Brief] [2]. Filippov S, et al. ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK. J Lipid Res. 2013 Aug;54(8):2095-108. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	2.9028 mL	14.5142 mL	29.0284 mL	72.5710 mL
	5 mM	0.5806 mL	2.9028 mL	5.8057 mL	14.5142 mL
	10 mM	0.2903 mL	1.4514 mL	2.9028 mL	7.2571 mL
	15 mM	0.1935 mL	0.9676 mL	1.9352 mL	4.8381 mL
	20 mM	0.1451 mL	0.7257 mL	1.4514 mL	3.6286 mL
	25 mM	0.1161 mL	0.5806 mL	1.1611 mL	2.9028 mL
	30 mM	0.0968 mL	0.4838 mL	0.9676 mL	2.4190 mL
	40 mM	0.0726 mL	0.3629 mL	0.7257 mL	1.8143 mL
	50 mM	0.0581 mL	0.2903 mL	0.5806 mL	1.4514 mL
	60 mM	0.0484 mL	0.2419 mL	0.4838 mL	1.2095 mL
	80 mM	0.0363 mL	0.1814 mL	0.3629 mL	0.9071 mL
	100 mM	0.0290 mL	0.1451 mL	0.2903 mL	0.7257 mL

Bempedoic acid Related Classifications

Metabolic Disease

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Bempedoic acid738606-46-7ETC-1002 ESP-55016ETC1002ETC 1002ESP55016ESP 55016ESP-55016ATP Citrate LyaseAMPKACLYAMP-activated protein kinaseInhibitorinhibitorinhibit

Vos produits récemment consultés:

Nom du produit

Requested Quantity *

Nom du demandeur *

Civilité

Adresse e-mail *

Numéro de téléphone *

Department

Nom de l'organisation *

City

État

Country or Region *

Remarques

Nom du produit

Lot #

Nom du demandeur *

Adresse e-mail *

Numéro de téléphone

Department *

Nom de l'organisation *

Country or Region *

Remarques

Nom
Email *

	Sorry, but the email address you supplied was invalid.

Bempedoic acid (Synonyms: ETC-1002; ESP-55016)

Avis client

Other Forms of Bempedoic acid:

Bempedoic acid Related Antibodies

22 Publications Citing Use of MCE Bempedoic acid

Recommandations en vedette

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Voir tous les produits spécifiques à Isoform AMPK:

Activité biologique

Protocole

Pureté et documentation

Références

Avis client

Bempedoic acid Related Antibodies

Calculateur de molarité

Calculateur de dilution

Complete Stock Solution Preparation Table

Bempedoic acid Related Classifications

Keywords:

Vos produits récemment consultés:

Avis client

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report